- Investing Ideas
- /
- Japanese Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals
Japanese Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals
Results
4
High return on equity, past performance and sound balance sheet.
4 companies
Chugai Pharmaceutical
Market Cap: JP¥10.9t
Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.
4519
JP¥6,638.00
7D
1.5%
1Y
29.4%
PeptiDream
Market Cap: JP¥244.1b
A biopharmaceutical company, engages in the discovery and development of constrained peptides, small molecules, and peptide-drug conjugate therapeutics.
4587
JP¥1,883.00
7D
2.2%
1Y
22.7%
WDB coco
Market Cap: JP¥7.7b
Provides contract services to pharmaceutical companies in Japan.
7079
JP¥3,215.00
7D
6.8%
1Y
-29.3%
Immuno-Biological Laboratories
Market Cap: JP¥4.2b
Engages in the research, development, manufacturing, and supply of various immunological research reagents worldwide.
4570
JP¥449.00
7D
5.9%
1Y
-1.5%